New perspec)ves on withdrawal from dialysis. Jennifer Chan, Phil Clayton, Stephen McDonald, John Agar, Ma?hew Jose
|
|
|
- Matthew Cole
- 5 years ago
- Views:
Transcription
1 New perspec)ves on withdrawal from dialysis Jennifer Chan, Phil Clayton, Stephen McDonald, John Agar, Ma?hew Jose
2 Figure 3.8 Cause of Death by RRT Modality Cause of Death 1-Jan-2009 to 31-Dec-2009 Australia New Zealand Dialysis Transplant Dialysis Transplant Cardiac C ardiac arrest Haemorrhagic Pericarditis Hy perkalaemia Hy pertensiv e cardiac failure My ocardial infarction My ocardial infarction (presumed) O ther causes of cardiac failure Pulmonary oedema Sub T otal 515 (34%) 33 (23%) 148 (45%) 9 (26%) Infection CNS - bacterial Lung - bacterial Lung -viral 4 (i) (sf) 3 (cmv ) - - Lung - fungal 2 (as) (ca ) 2 (as) - - Lung - protozoa - 1 (pn) - - Lung - other 6 (ni) 1 (ni) 2 (ni) 1 (ni) Urinary tract - bacterial Urinary tract - fungal 1 (ca) Wound - ba cterial Wound - fungal 2 (ca) Wound - other 1 (ni) Shunt - bacterial Peritoneum - bacterial Peritoneum - fungal 3 (ca) - 3 (ca) - Peritoneum - other (ni) - Septicaemia - bacterial Septicaemia - fungal - 2 (cr) 1 (ca) - Septicaemia - other 9 (ni) - 2 (ni) - Liv er - viral 3 (hb) 1 (hb) 1 (hb) - O ther site - bacterial O ther site - viral - 1 (cmv ) - - O ther site - other (ni) - Sub T otal 176 (12%) 28 (20%) 46 (14%) 3 (9%) Vascular Bowel infarction C erebrov ascular accident Gastrointestinal haemorrhage Haemorrhage - dialy sis access site Haemorrhage - elsew here Pulmonary embolus Ruptured aortic aneury sm Sub T otal 137 (9%) 17 (12%) 32 (10%) - Social A ccident Patient refused treatment Suicide Therapy ceased Withdraw al - access problems Withdraw al - cardiov ascular Withdraw al - cerebrov ascular Withdraw al - malignancy Withdraw al - periphe ral v ascular Withdraw al - psy chosocial Sub Total 565 (37%) 11 (8%) 83 (25%) 2 (6%) Miscellaneous C achexia C hronic respiratory failure Hepatic failure Malignancy O ther Pancreatitis Perforation abdominal v iscus Sclerosing peritonitis Uraemia caused by graft failure Unknow n Sub T otal 132 (9%) 52 (37%) 22 (7%) 20 (59%) Cardiac 34% Infection 12% Vascular 9% Cause of death on dialysis Social causes 37% Misc including cancer 9% Total (100%) (as) aspergillus (ca) candida (cmv ) cmv (cr) cry ptococcus (hb) hepatitis b (i) influenza (sf) sw ine flu (pn) pneumocystis (ni) organism not isolated ANZDATA Registry
3 Pre-October 2003 Dialysis withdrawal: Coding
4 Pre-October 2003 Dialysis withdrawal: Coding
5 Study: Dialysis withdrawal in Australia and New Zealand ANZDATA source Incident cohort Follow-up to end 2008 n=28,884 Of which there were 10,073 deaths
6 Incident pa)ents Overall cohort DW deaths Non-DW deaths P-value! Total Number of patients, N Age at the time of RRT (years) 59±15 69±11 64±13 <0.001 Male, N (%) (59.6) 1625 (57.1) 4265(59.0) BMI at entry (kg/m 2 ) 27±6 26±6 27±6 <0.001 Racial origin <0.001 Caucasian, N (%) Asian, N (%) Aboriginal/Torres Strait Islander, N (%) M!ori, N (%) Pacific Islander, N (%) Other, N (%) (73.9) 1646 (6.6) 1921 (7.7) 1514 (6.1) 997 (4.0) 416 (1.7) 2399 (84.4) 113 (4.0) 136 (4.8) 122 (4.3) 56 (2.0) 18 (0.6) 5195(71.9) 365(5.0) 643(8.9) 657(9.1) 290(4.0) 79(1.1) Comorbidity at entry Diabetes mellitus, N (%) Chronic lung disease, N (%) Coronary artery disease, N (%) Peripheral vascular disease, N (%) Cerebrovascular disease, N (%) (41.2) 3926 (15.8) 9867 (39.7) 6414 (25.8) 3738 (15.0) 1239 (43.6) 606 (21.3) 1588 (55.8) 1087 (38.2) 740 (26.0) 3591(49.7) 1562(21.6) 3912(54.1) 2605(36.0) 1483(20.5) < <0.001 Late referral, N (%) 6021 (24.2) 833 (29.3) 2050(28.4) 0.352!
7 Dialysis withdrawal: Cause of death Time period Total number of patients, N Patient refused further treatment, N (%) 392 (56.8) 4 (0.2) Therapy ceased for any other reason, N (%) 227 (32.9) 38 (1.8) Suicide, N (%) 12 (1.7) 12 (0.6) Withdrawal for psychosocial reasons, N (%) 20 (2.9) 832 (38.6) Withdrawal for cardiovascular comorbid conditions, N (%) 14 (2.0) 348 (16.2) Withdrawal for cerebrovascular comorbid conditions, N (%) 10 (1.4) 212 (9.8) Withdrawal for peripheral vascular comorbid conditions, N (%) 6 (0.9) 265 (12.3) Withdrawal related to malignancy, N (%) 7 (1.0) 345 (16.0) Withdrawal related to dialysis access difficulties, N (%) 2 (0.3) 98 (4.5)!
8 Cause of death
9 Dialysis withdrawal: Unit varia)on
10 Dialysis withdrawal: Unit varia)on #!!" +!" *!" )!"!"#$%&'($)*+,%(%&-'.''' (!" '!" &!" %!" $!" #!"!"!" $!!" &!!" (!!" *!!" #!!!" #$!!" /0123,'"4'5%637)'
11 Dialysis withdrawal: Age
12 Dialysis withdrawal: Place
13 Dialysis withdrawal: Remoteness Cause of death by location of renal unit by 5 year era Cause of death 5 year era Location Major Cities, N (%) Cardiac Vascular Infection Social malignancy Other Total, N (%) 1116(34.7) 292(9.1) 326(10.1) 1115(34.7) 203(6.3) 162(5) 3214(100) Inner Regional, N (%) 312(35) 75(8.4) 92(10.3) 305(34.2) 76(8.5) 31(3.5) 891(100) Outer Regional, N (%) 207(40.3) 47(9.1) 69(13.4) 121(23.5) 38(7.4) 32(6.2) 514(100) Remote, N (%) 71(42.5) 17(10.2) 28(16.8) 33(19.8) 6(3.6) 12(7.2) 167(100) Very Remote, N (%) 34(48.6) 9(12.9) 6(8.6) 9(12.9) 6(8.6) 6(8.6) 70(100) Total, N (%) 1740(35.8) 440(9.1) 521(10.7) 1583(32.6) 329(6.8) 243(5) 4856(100)
14 Early withdrawal? 10 Cumulative incidence (%) Other Withdrawal 3.5% Per Annum Months Number at risk
15 Predictors of withdrawal! Univariate Analysis Multivariate Analysis Variable N SHR * P-value SHR * P-value Age (per decade) ( ) < ( ) <0.001 Male sex ( ) ( ) <0.001 Race Caucasian Indigenous Other 1 (reference) 1 (reference) ( ) <0.001 # 0.74 ( ) # 0.49 ( ) 0.66 ( ) Late referral ( ) < ( ) <0.001 Diabetes ( ) ( ) 0.05 Comorbid burden ( ) < ( ) <0.001 Peritoneal dialysis ( ) < ( ) <0.001 Remoteness Major cities Inner regional Outer regional Remote Very remote 1 (reference) ( ) ( ) 0.02 # ( ) ( ) - - * SHR, subhazard ratio (95% confidence interval) # P-value for category as a whole Only available for Australian patients
16 Conclusion Dialysis withdrawal is common Unit coding is variable Risk factors in the first year include older age, female sex, Caucasian race, comorbid burden, use of HD and late referral to nephrologist. Acknowledgements We are grateful to the Australia and New Zealand renal units, patients and staffs for their cooperation and contribution to ANZDATA
CHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston
CHAPTER 3 DEATHS Stephen McDonald Leonie Excell Brian Livingston DEATHS ANZDATA Registry 2008 Report INTRODUCTION AUSTRALIA NEW ZEALAND The total number of deaths was 1,452 (15.4 deaths per 100 patient
Chapter 10. Cancer. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015
Chapter Cancer 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Incidence of Cancer on Renal Replacement Therapy Figures.1-.6 and table.1 show the cumulative incidence of non-skin cancer in patients
Chapter 2. Prevalence of End Stage Kidney Disease. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015
Chapter 2 Prevalence of End Stage Kidney Disease 2016 ANZDATA Registry 39th Annual Report Data to 31-Dec-2015 Renal Replacement Therapy Table 2.1 shows the prevalence (pmp) of renal replacement therapy
Chapter 15: Causes of Death on Renal Replacement Therapy
Chapter 15: Causes of Death on Renal Replacement Therapy Summary Cardiovascular disease is the most common cause of death in the renal population and is most evident in diabetics. Patients on renal replacement
STOCK and FLOW. ANZDATA Registry 2011 Report CHAPTER 1 STOCK & FLOW. Blair Grace Kylie Hurst Stephen McDonald 1-1
CHAPTER 1 STOCK & FLOW Blair Grace Kylie Hurst Stephen McDonald 1-1 ANZDATA Registry 2011 Report The number of new patients in Australia decreased slightly to 2257 in 2010. While there is variation in
Chapter 10. Cancer. ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong.
Chapter Cancer ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong Contents: Cancer -1 Incidence of Cancer on Renal Replacement Therapy -2 Kidney Cancer
CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease
CHAPTER 2 Prevalence of Renal Replacement Therapy for End Stage Kidney Disease Summarising the number of prevalent renal replacement therapy patients in and, the prevalence rate per million population
CHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition
CHAPTER 6 Neil Boudville Hannah Dent Stephen McDonald Kylie Hurst Philip Clayton 213 Annual Report - 36th Edition ANZDATA Registry 213 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis was used to treat
Association between causes of peritoneal dialysis technique failure and all-cause mortality
www.nature.com/scientificreports Received: 27 September 2017 Accepted: 21 February 2018 Published: xx xx xxxx OPEN Association between causes of peritoneal dialysis technique failure and all-cause mortality
CHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst 212 Annual Report 35th Edition PERITONEAL DIALYSIS ANZDATA Registry 212 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis
Chapter 7. Australian Waiting List. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015
Chapter 7 Australian Waiting List 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Stock and Flow The waiting list data reported here are derived from the Australian National Organ Matching System
CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease
CHAPTER 2 Prevalence of Renal Replacement Therapy for End Stage Kidney Disease Summarising the number of prevalent renal replacement therapy patients in Australia and New Zealand, the prevalence rate per
CHAPTER 6 PERITONEAL DIALYSIS
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani Hannah Dent Kylie Hurst Stephen McDonald PERITONEAL DIALYSIS ANZDATA Registry 11 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis was used to
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1
ANZDATA Registry 213 Report INDIGENOUS END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12 Stephen McDonald Matthew Jose Kylie Hurst 213 Annual Report - 36th Edition
CHAPTER 5. Haemodialysis. Kevan Polkinghorne Hannah Dent Aarti Gulyani Kylie Hurst Stephen McDonald
CHAPTER Haemodialysis Kevan Polkinghorne Hannah Dent Aarti Gulyani Kylie Hurst Stephen McDonald STOCK AND FLOW AUSTRALIA The annual stock and flow of HD patients during the period - is shown in Figures.,.
CHAPTER 12 CARDIOVASCULAR MORTALITY OF PATIENTS WHO COMMENCE DIALYSIS WITHOUT CLINICAL EVIDENCE OF CARDIOVASCULAR DISEASE
CHPTER CRDIOVSCULR MORTLITY OF PTIENTS WHO COMMENCE DILYSIS WITHOUT CLINICL EVIDENCE OF CRDIOVSCULR DISESE Matthew Roberts Kevan Polkinghorne Stephen McDonald Francesco Ierino CRDIOVSCULR MORTLITY NZDT
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Matthew Jose Stephen McDonald Leonie Excell
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG PEOPLES OF AUSTRALIA AND NEW ZEALAND Matthew Jose Stephen McDonald Leonie Excell INTRODUCTION Rates of end-stage kidney disease among the Peoples of and are substantially
CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2007
CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 27 Stephen McDonald Leonie Excell Hannah Dent NEW PATIENTS ANZDATA Registry 28 Report Figure 2.1 Annual Intake of New Patients 23-27 (Number Per Million Population)
CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand
CHAPTER 9 End Stage Kidney Disease in Aotearoa/New Zealand ANZDATA gratefully acknowledges the patients and their families and the clinicians who provided data, and the contributions of the Aotearoa/New
Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations
NDT Advance Access published November 9, 2005 Nephrol Dial Transplant (2005) 1 of 8 doi:10.1093/ndt/gfi248 Original Article Effect of previously failed kidney transplantation on peritoneal dialysis outcomes
State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE
Dear State Surveyor: State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE This report is designed to provide a comparative summary of treatment patterns and patient outcomes for
2011 Dialysis Facility Report
Purpose of the Report 2011 Dialysis Facility Report Enclosed is the 2011 Dialysis Facility Report (DFR) for your facility, based on data from the Centers for Medicare & Medicaid Services (CMS). This DFR
Chapter 1. Incidence of End Stage Kidney Disease. Contents:
Chapter 1 Incidence of End Stage Kidney Disease Contents: Incidence of End Stage Kidney Disease 1-1 Stock and Flow 1-2 Incident patients 1-3 Incident Rates 1-3 Late Referral 1-7 Co-Morbidities 1-9 Primary
Allocation of deceased donor kidneys. Phil Clayton NSW Renal Group 14 June 2012
Allocation of deceased donor kidneys Phil Clayton NSW Renal Group 14 June 2012 Outline Why study kidney allocation? Equity vs utility Current Australian model Previous work in Australia US allocation research
Princess Alexandra Hospital, Brisbane
Princess Alexandra Hospital Coagulase Negative Staphylococcal Peritonitis in Australian Peritoneal Dialysis Patients Predictors, Treatment and Outcomes in 936 cases Dr Magid Fahim Princess Alexandra Hospital,
CHAPTER 4 METHOD AND LOCATION OF DIALYSIS. Nancy Briggs Kylie Hurst Stephen McDonald Annual Report 35th Edition
CHAPTER 4 METHOD AND LOCATION OF DIALYSIS Nancy Briggs Kylie Hurst Stephen McDonald 212 Annual Report 35th Edition METHOD AND LOCATION OF DIALYSIS ANZDATA Registry 212 Report AUSTRALIA Figure 4.1 Aust
2011 Dialysis Facility Report SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE Dialysis Facility Report SAMPLE
Purpose of the Report Enclosed is the (DFR) for your facility, based on data from the Centers for Medicare & Medicaid Services (CMS). This DFR includes data specific to CCN(s): 999999 These data could
Outcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote
Outcomes of dialysis in the elderly DNT March 2011 Dr Céline Foote Increasing number of elderly patients on renal replacement therapy 500 500 Patients per million 400 300 200 100 400 300 200 100 TOTAL
Appendix G Coding: Ethnicity, EDTA Primary Renal Diagnoses, EDTA Causes of Death and Treatment Timeline Modality Codes
Coding: Ethnicity, EDTA Primary Renal Diagnoses, EDTA Causes of Death and Treatment Timeline Modality Codes G1: Ethnicity coding Ethnicity data is recorded in the clinical information systems in the individual
Full Novartis CTRD Results Template
Full Novartis CTRD Results Template Sponsor Novartis Generic Drug Name vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Type 2 diabetes Protocol Number CLAF237A23138E1 Title A
Acceptance onto dialysis guidelines: St George Hospital
Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines
Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report
Chapter 12 End Stage Kidney Disease in Indigenous Peoples of and Aotearoa/ 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, the rates and practice patterns for end-stage
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand
Chapter 12 End Stage Kidney Disease Among Indigenous Peoples of and New Zealand 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, rates of end-stage kidney disease
Ontario s Referral and Listing Criteria for Adult Kidney Transplantation
Ontario s Referral and Listing Criteria for Adult Kidney Transplantation Version 3.0 Trillium Gift of Life Network Adult Kidney Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The
Peritoneal dialysis in rural Australia
Gray et al. BMC Nephrology 2013, 14:278 RESEARCH ARTICLE Peritoneal dialysis in rural Australia Nicholas A Gray 1,2,3*, Blair S Grace 3,4 and Stephen P McDonald 3,4,5 Open Access Abstract Background: Australians
Dialysis and Transplantation Audit
New Zealand Dialysis and Transplantation Audit and A summary report of activity for New Zealand nephrology services Dr Suetonia Palmer On behalf of the National Renal Advisory Board NRAB Standard and Audits
Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease
http://www.kidney-international.org & 2012 International Society of Nephrology clinical investigation Anti-glomerular basement membrane antibody is an uncommon cause of end-stage renal Wen Tang 1,2,3,
2015 Children's Mercy Hospitals and Clinics. All Rights Reserved.
Growth van Stralen KJ, et al., Kidney Int, 2014 Blood Pressure Management van Stralen KJ, et al., Kidney Int, 2014 Sodium Losses on PD Infants might need higher UF rate per BSA as compared to adults to
2012 Dialysis Facility Report
Purpose of the Report 212 Dialysis Facility Report The 212 Dialysis Facility Report (DFR) is provided as a resource for characterizing selected aspects of clinical experience at this facility relative
2010 Dialysis Facility Report
Purpose of the Report 2010 Dialysis Facility Report Enclosed is the 2010 Dialysis Facility Report (DFR) for this facility, based on data from the Centers for Medicare & Medicaid Services (CMS). This DFR
Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation
Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation Version 2.0 Trillium Gift of Life Network Adult Pancreas-After-Kidney Transplantation Referral & Listing Criteria
2008 Dialysis Facility Report
iii Purpose of the Report Enclosed is the (DFR) for this facility, based on data from the Centers for Medicare & Medicaid Services (CMS). This DFR includes data specific to provider number(s): 102844 These
Yes No Unknown. Major Infection Information
Rehospitalization Intervention Check any that occurred during this hospitalization. Pacemaker without ICD ICD Atrial arrhythmia ablation Ventricular arrhythmia ablation Cardioversion CABG (coronary artery
A tale of two specialties
A tale of two specialties United Kingdom Annual Symposia on Renal-Palliative Care co-organised by both disciplines National Service Framework for Renal Services Part 2 (UK) - 2005 Concentrated on the
Marginal Dialysis: Patient characteristics influencing outcomes
Marginal Dialysis: Patient characteristics influencing outcomes Dr Celine Foote Staff specialist, Concord Repatriation General Hospital Post-Doctoral Research Fellow, The George Institute for Global Health
RENINE Annual Report 2015
RENINE Annual Report 2015 T. Hoekstra, M.H. Hemmelder, F.J. van Ittersum In cooperation with the sectie Registratie (Registration division) of the Nederlandse Federatie voor Nefrologie (NfN; Dutch federation
CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster
CHAPTER 10 CANCER REPORT Jeremy Chapman and Angela Webster CANCER REPORT ANZDATA Registry 2004 Report This report summarises the cancer (excluding nonmelanocytic skin cancer) experience of patients treated
PATIENTS WHO WITHDRAW FROM DIALYSIS. Dr Katalin Urban Palliative Care Specialist Greenwich Hospital
PATIENTS WHO WITHDRAW FROM DIALYSIS Dr Katalin Urban Palliative Care Specialist Greenwich Hospital Registrar project for FRACP Title: Patients who withdraw from dialysis in a Sydney centre with Palliative
Burden of end-stage renal disease
Summary of Indigenous health: End-stage renal disease Neil Thomson and Sasha Stumpers Australian Indigenous HealthInfoNet, Edith Cowan University www.healthinfonet.ecu.edu.au This summary of end-stage
Palliative and End of Life Care in End Stage Renal Disease
Palliative and End of Life Care in End Stage Renal Disease Palliative and End of Life Care Priority for Action Regional Consensus Workshop 30.06.2010 Neal Morgan Consultant Nephrologist SHSCT Outline Introduction
Supplementary Online Content
Supplementary Online Content Irish AB, Viecelli AK, Hawley CM, et al; for the Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.
Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand
Kidney International, Vol. 63, Supplement 83 (2003), pp. S123 S127 Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand STEPHEN P. MCDONALD and GRAEME R. RUSS ANZDATA
Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: Secondary Outcome/Efficacy Variable(s): Statistical Methods:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
Original Articles. Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis
Nephrol Dial Transplant (2014) 29: 1940 1947 doi: 10.1093/ndt/gfu050 Advance Access publication 3 March 2014 Original Articles Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis
Transition between home dialysis modalities another piece in the jigsaw of the integrated care pathway.
Transition between home dialysis modalities another piece in the jigsaw of the integrated care pathway. Mark Lambie and Simon J Davies Health Services Research Unit, Institute for Science and Technology
Substance Use Among Potential Kidney Transplant Candidates and its Impact on Access to Kidney Transplantation: A Canadian Cohort Study
Substance Use Among Potential Kidney Transplant Candidates and its Impact on Access to Kidney Transplantation: A Canadian Cohort Study Evan Tang 1, Aarushi Bansal 1, Michelle Kwok 1, Olusegun Famure 1,
RENINE year report 2016
RENINE year report 216 T. Hoekstra, F.J. van Ittersum and M.H. Hemmelder In cooperation with the sectie Registratie (Registration division) of the Nederlandse Federatie voor Nefrologie (NfN; Dutch federation
This appendix was part of the submitted manuscript and has been peer. Pre-existing cardiovascular disease was defined by the presence of any of the
Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors Additional methods Defining comorbidities Pre-existing cardiovascular disease
Chapter 8: Cardiovascular Disease in Patients with ESRD
Chapter 8: Cardiovascular Disease in Patients with ESRD Cardiovascular disease (CVD) is common in adult end-stage renal disease (ESRD) patients, with coronary artery disease (CAD) and heart failure (HF)
MORE than a quarter of a million end-stage
VI. Causes of Death INDEX WORDS: Cardiac deaths; death rates; diabetic ESRD; hemodialysis; infection in ESRD; malignancy in dialysis; peritoneal dialysis; transplant deaths; withdrawal from dialysis. MORE
TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA
& TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA 2002-2008 Halima Resić* 1, Enisa Mešić 2 1 Clinic for Hemodialysis, University of Sarajevo Clinics Centre, Bolnička 25, 71000 Sarajevo, Bosnia
Michael Minarich, MD General Surgery Resident, PGY4 Cooper University Hospital
BMI as Major Preoperative Risk Factor for Intraabdominal Infection After Distal Pancreatectomy: an Analysis of National Surgical Quality Improvement Program Database Michael Minarich, MD General Surgery
Dialysis Mortality Regional Clinical Audit Report 2011
Dialysis Mortality Regional Clinical Audit Report 2011 Clinical Audit Lead: Authors: Dr Iren Szeki Consultant Nephrologist, Manchester Royal Infirmary Dr Iren Szeki, Consultant Nephrologist Dr Helen Alderson,
Management of the Frail Older Patients: What Are the Outcomes
Management of the Frail Older Patients: What Are the Outcomes Professor Edwina Brown Imperial College Renal and Transplant Centre Hammersmith Hospital, London Increasing prevalence of old old on RRT RRT
Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty
Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty A Review of ACS-NSQIP 2006-2012 Arjun Sebastian, M.D., Stephanie Polites, M.D., Kristine Thomsen, B.S., Elizabeth Habermann,
Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).
Appendix Definitions of Index Admission and Readmission Definitions of index admission and readmission follow CMS hospital-wide all-cause unplanned readmission (HWR) measure as far as data are available.
JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012
SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
Chapter 9. Kidney Donors. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015
Chapter 9 Kidney Donors 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Deceased Kidney Donors The data for this section come from the Australia and New Zealand Organ Donor (ANZOD) Registry.
Outcomes of chronic dialysis in Korean children with respect to survival rates and causes of death
Original article Korean J Pediatr 2014;57(3):135-139 pissn 1738-1061 eissn 2092-7258 Korean J Pediatr Outcomes of chronic dialysis in Korean children with respect to survival rates and causes of death
Chapter 9: Cardiovascular Disease in Patients With ESRD
Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in adult ESRD patients, with atherosclerotic heart disease and congestive heart failure being the most common conditions
Appendix C: Renal Services Described for Non-physicians
Appendix C: Renal Services Described for Non-physicians (Reproduced from the third edition of the Renal Association Standards document, August 2002.) This appendix provides information on the issues discussed
Variable Included. Excluded. Included. Excluded
Table S1. Baseline characteristics of patients included in the analysis and those excluded patients because of missing baseline serumj bicarbonate levels, stratified by dialysis modality. Variable HD patients
An epidemic of renal failure among Australian Aboriginals
emja Australia The Medical Journal of Home Issues emja shop Classifieds Contact More... Topics Search Login Buy full access An epidemic of renal failure among Australian Aboriginals Janine L Spencer, Desiree
CHAPTER 10 CANCER REPORT. Angela Webster Germaine Wong
CHAPTER 10 Angela Webster Germaine Wong ANZDATA Registry 2008 Report This year the cancer report contains results of a new ANZDATA analysis on survival after cancer diagnosis, and also shows how ANZDATA
Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
Chapter 2: Identification and Care of Patients With Chronic Kidney Disease
Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets
Appendix 1: Supplementary tables [posted as supplied by author]
![Appendix 1: Supplementary tables [posted as supplied by author]](/thumbs/81/83505567.jpg "Appendix 1: Supplementary tables [posted as supplied by author]")
Appendix 1: Supplementary tables [posted as supplied by author] Table A. International Classification of Diseases, Ninth Revision, Clinical Modification Codes Used to Define Heart Failure, Acute Myocardial
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia
clinical investigation http://www.kidney-international.org & 212 International Society of Nephrology see commentary on page 18 Transplantation rates for living- but not deceased-donor kidneys vary with
OUT OF DATE. Coronary artery, cerebrovascular and peripheral vascular disease
19..23 NEPHROLOGY 2010; 15, S19 S23 doi:10.1111/j.1440-1797.2010.01227.x Coronary artery, cerebrovascular and peripheral vascular disease Date written: December 2008 Final submission: March 2009nep_1227
Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia
Supplementary Table S1 International Classification of Disease 10 (ICD-10) codes Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care I48 AF
Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand,
Nephrol Dial Transplant (2002) 17: 2212 2219 Original Article Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991
Supplementary Online Content
Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis
FIRST RENAL REPLACEMENT
FIRST RENAL REPLACEMENT THERAPY SELECTION IN DIABETIC PATIENTS Dr Cécile Couchoud (REIN registry, France) Davide Bolignano (ERBP, Italy) European Renal Best Practice Prof. Wim Van Biesen Chairman of ERBP
The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival
ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,
New Zealand. Dialysis and Transplantation Audit
New Zealand Dialysis and Transplantation Audit Report for New Zealand Nephrology Services on behalf of the National Renal Advisory Board Grant Pidgeon Standards and Audit Subcommittee July 2012 Establishment
Ontario s Referral and Listing Criteria for Adult Heart Transplantation
Ontario s Referral and Listing Criteria for Adult Heart Transplantation Version 3.0 Trillium Gift of Life Network Adult Heart Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The
STEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL
MAIN OFFICE: (618) 692-7478 MORGUE: (618) 296-4525 FAX: (618) 692-6042 FAX: (618) 692-9304 STEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL. 62025-1962
Supplemental Appendix. 1. Protocol Definition of Sustained Virologic Response. A patient has a sustained virologic response if:
Supplemental Appendix 1. Protocol Definition of Sustained Virologic Response A patient has a sustained virologic response if: 1. The patient is a responder at the end of treatment and all subsequent planned
Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis
CJASN epress. Published on June 21, 2017 as doi: 10.2215/CJN.12321216 Article Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal
Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009
Western University Scholarship@Western Electronic Thesis and Dissertation Repository June 2015 Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009 Ngan Lam The University
The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century?
The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century? By: Baskar, WDHB, Renal Service Auckland New Zealand Presented at : 4 th International Conference on
USRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in ESRD patients, with atherosclerotic heart disease and congestive heart
Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients
http://www.kidney-international.org & 006 International Society of Nephrology Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients MR Marshall,
Anoxic insult Stroke/Cerebrovascular accident
Page 1 of 5 Patient Details Hidden Show Show/Hide Annotations Stickies: Toggle All Toggle Open Toggle Resolved Form 10: Death Print this Form t Started 1 Date of Death MM/DD/YYYY 2 Primary cause of death
Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture
Technical Appendix Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture and Associated Surgical Treatment ICD 9 Code Descriptions Hip Fracture 820.XX Fracture neck of femur 821.XX
Transplantation in Australia and New Zealand
Transplantation in Australia and New Zealand Matthew D. Jose MBBS (Adel), FRACP, FASN, PhD (Monash), AFRACMA Professor of Medicine, UTAS Renal Physician, Royal Hobart Hospital Overview CKD in Australia
Disparities in Transplantation Caution: Life is not fair.
Disparities in Transplantation Caution: Life is not fair. Tuesday October 30 th 2018 Caroline Rochon, MD, FACS Surgical Director, Kidney Transplant Program Hartford Hospital, Connecticut Outline Differences